Publications by authors named "Georgette M Buga"

Claim this Profile
T
Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid.
Mohamad Navab, Greg Hough, Georgette M Buga, Feng Su, Alan C Wagner

J Lipid Res· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature.
Mohamad Navab, Srinivasa T Reddy, Brian J Van Lenten, Georgette M Buga, Greg Hough

Arterioscler Thromb Vasc Biol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice.
Mohamad Navab, Srinivasa T Reddy, G M Anantharamaiah, Greg Hough, Georgette M Buga

J Lipid Res· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
L-4F alters hyperlipidemic (but not healthy) mouse plasma to reduce platelet aggregation.
Georgette M Buga, Mohamad Navab, Satoshi Imaizumi, Srinivasa T Reddy, Babak Yekta

Arterioscler Thromb Vasc Biol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apolipoprotein A-I mimetic peptides.
Brian J Van Lenten, Alan C Wagner, G M Anantharamaiah, Mohamad Navab, Srinivasa T Reddy, Georgette M Buga

Curr Atheroscler Rep· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple indications for anti-inflammatory apolipoprotein mimetic peptides.
Brian J Van Lenten, Mohamad Navab, G M Anantharamaiah, Georgette M Buga, Srinivasa T Reddy

Curr Opin Investig Drugs· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet.
Georgette M Buga, Joy S Frank, Giuliano A Mottino, Ashkan Hakhamian, Ajay Narasimha

J Lipid Res· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide Mimetics of Apolipoproteins Improve HDL Function.
Mohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, Brian J Van Lenten, Georgette M Buga

J Clin Lipidol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet.
Georgette M Buga, Joy S Frank, Giuliano A Mottino, Michael Hendizadeh, Ashkan Hakhamian

J Lipid Res· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor-mediated vascular responsiveness to nebivolol: a novel endothelium-related mechanism of therapeutic vasorelaxation.
Hermes J Garbán, Georgette M Buga, Louis J Ignarro

J Cardiovasc Pharmacol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitors of nitric oxide promote microvascular thrombosis.
Babak Azizzadeh, Georgette M Buga, Gerald S Berke, Babak Larian, Louis J Ignarro

Arch Facial Plast Surg· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunosuppressive effects of interleukin-12 coexpression in melanoma antigen gene-modified dendritic cell vaccines.
Antoni Ribas, Saral N Amarnani, Georgette M Buga, Lisa H Butterfield, Vivian B Dissette

Cancer Gene Ther· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nebivolol: a selective beta(1)-adrenergic receptor antagonist that relaxes vascular smooth muscle by nitric oxide- and cyclic GMP-dependent mechanisms.
Louis J Ignarro, Russell E Byrns, Kim Trinh, Manisha Sisodia, Georgette M Buga

Nitric Oxide· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nebivolol inhibits vascular smooth muscle cell proliferation by mechanisms involving nitric oxide but not cyclic GMP.
Louis J Ignarro, Manisha Sisodia, Kim Trinh, Sahar Bedrood, Guoyao Wu, Georgette M Buga

Nitric Oxide· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis